Effect of hepatic impairment on the pharmacokinetics of vilaprisan: An open‐label, single‐dose, parallel‐group study
2019 ◽
Vol 85
(9)
◽
pp. 2011-2021
◽
2017 ◽
Vol 55
(01)
◽
pp. 41-53
◽
Keyword(s):
2009 ◽
Vol 31
◽
pp. 2459-2469
◽
2013 ◽
Vol 35
(6)
◽
pp. 782-794
◽
2021 ◽
Vol 116
(1)
◽
pp. S327-S328
Keyword(s):
2013 ◽
Vol 35
(3)
◽
pp. 215-225
◽
2015 ◽
Vol 79
(6)
◽
pp. 937-945
◽
2015 ◽
Vol 53
(10)
◽
pp. 847-854
◽
Keyword(s):
2017 ◽
Vol 57
(3)
◽
pp. 345-354
◽
Keyword(s):
2015 ◽
Vol 2
(31)
◽
pp. 4568-4573
◽
Keyword(s):